Company Filing History:
Years Active: 2018
Title: Jennifer Abscheidt: Innovator in Genetic Detection
Introduction
Jennifer Abscheidt is a prominent inventor based in Nogent-Sur-Marne, France. She has made significant contributions to the field of genetics, particularly in the detection of sequence amplifications related to the BRCA1 locus. Her work is crucial for understanding predispositions to certain cancers, including ovarian and breast cancer.
Latest Patents
Jennifer holds a patent titled "Methods for the detection of sequence amplification in the BRCA1 locus." This patent outlines innovative methods for detecting amplifications of sequences in the BRCA1 locus. The methods involve identifying sequences that are present at least twice in the BRCA1 locus and determining predispositions to diseases associated with these amplifications.
Career Highlights
Jennifer is currently associated with Genomic Vision, a company that focuses on genomic analysis and diagnostics. Her expertise in genetic detection has positioned her as a key player in the field, contributing to advancements in cancer research and diagnostics.
Collaborations
Throughout her career, Jennifer has collaborated with notable professionals, including Maurizio Ceppi and Emmanuel Conseiller. These collaborations have further enhanced her research and development efforts in genetic detection.
Conclusion
Jennifer Abscheidt's innovative work in genetic detection has made a significant impact on the understanding of cancer predispositions. Her contributions continue to advance the field of genomics and improve diagnostic methods for critical health issues.